Metagenome
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Probiotic Research: Open-label Functional Intervention and Longitudinal Evaluation in Healthy Adults
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Polish Microbiome Map
Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement